Literature DB >> 23767380

HLA class I & II alleles in multiple sclerosis patients from Puerto Rico.

María T Miranda1, Erick Suárez, Muneer Abbas, Angel Chinea, Rafael Tosado, Ida A Mejías, Nawal Boukli, Georgia M Dunston.   

Abstract

Multiple Sclerosis (MS) is a complex disease where genetic and environmental factors have been implicated. The onset of symptoms occurs in individuals from twenty to fifty years of age, producing a progressive impairment of motor, sensory and cognitive functions. MS is more frequent in females than in males with a ratio of 4:1. The prevalence of the MS varies among ethnics groups such as Europeans, Africans and Caucasians. The estimated prevalence of MS in Puerto Rico is 42 for each 100,000 habitants, which is more than the prevalence reported for Central America and the Caribbean. In spite of this prevalence, the genetic component of MS has not been explored in order to know the alleles' expression of Puerto Rican MS patients and compare it with the allele expression in other ethnic groups. Thirty-five patients and 31 control subjects were genotyped. The allele frequencies expressed in this sample were similar to those expressed for Puerto Ricans in the National Marrow Donor Program Registry (n = 3,149). The most prevalent alleles for MS patients were HLA-DRB1*01 and *03. HLA-DQB1*04 was the most frequent in the control group and HLA-A*30, in MS patients. These findings are in agreement with published data. HLA-DQB1*04 was a marginal protector in this sample and this role has not been described before. The accuracy of the results is limited due to the sample size. After performing a statistical power analysis it showed that by increasing the sample the values would be significant.

Entities:  

Mesh:

Year:  2013        PMID: 23767380      PMCID: PMC4573578     

Source DB:  PubMed          Journal:  Bol Asoc Med P R        ISSN: 0004-4849


  24 in total

1.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.

Authors:  Ranjan Dutta; Jennifer McDonough; Xinghua Yin; John Peterson; Ansi Chang; Thalia Torres; Tatyana Gudz; Wendy B Macklin; David A Lewis; Robert J Fox; Richard Rudick; Karoly Mirnics; Bruce D Trapp
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

2.  Multiple sclerosis in Latin America.

Authors:  Teresa Corona; Gustavo C Román
Journal:  Neuroepidemiology       Date:  2005-10-25       Impact factor: 3.282

3.  A high-density screen for linkage in multiple sclerosis.

Authors:  Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J Daly; Philip L De Jager; Emily Walsh; Eric S Lander; John D Rioux; David A Hafler; Adrian Ivinson; Jacqueline Rimmler; Simon G Gregory; Silke Schmidt; Margaret A Pericak-Vance; Eva Akesson; Jan Hillert; Pameli Datta; Annette Oturai; Lars P Ryder; Hanne F Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David Booth; Robert Heard; Graeme Stewart; Robin Lincoln; Lisa F Barcellos; Stephen L Hauser; Jorge R Oksenberg; Shannon J Kenealy; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

4.  A population-based study of multiple sclerosis in twins: update.

Authors:  A D Sadovnick; H Armstrong; G P Rice; D Bulman; L Hashimoto; D W Paty; S A Hashimoto; S Warren; W Hader; T J Murray
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

Review 5.  Genetic epidemiology of multiple sclerosis: a survey.

Authors:  A D Sadovnick
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

6.  Genetic association of multiple sclerosis and HL-A determinants.

Authors:  M Alter; M Harshe; V E Anderson; L Emme; E J Yunis
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

Review 7.  Pathogenesis of multiple sclerosis: an update on immunology.

Authors:  Bernhard Hemmer; Sabine Cepok; Stefan Nessler; Norbert Sommer
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

8.  Epidemiology and etiology of multiple sclerosis.

Authors:  John F Kurtzke
Journal:  Phys Med Rehabil Clin N Am       Date:  2005-05       Impact factor: 1.784

9.  Multiple sclerosis: updated risks for relatives.

Authors:  A D Sadovnick; P A Baird; R H Ward
Journal:  Am J Med Genet       Date:  1988-03

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  2 in total

Review 1.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

2.  Impact of delayed treatment on exacerbations of multiple sclerosis among Puerto Rican patients.

Authors:  Sara Zarei; Irvin Maldonado; Laura Franqui-Dominguez; Cristina Rubi; Yanibel Tapia Rosa; Cristina Diaz-Marty; Guadalupe Coronado; Marimer C Rivera Nieves; Golnoush Akhlaghipour; Angel Chinea
Journal:  Surg Neurol Int       Date:  2019-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.